maintenance glp 1 GLP-1 Weight Loss NYC Metabolic Maintenance Protocol
Description
Several studies suggest that 15%-40% of IBD patients are obese
TIIDM is primarily found in middle-aged and elderly individuals
New data is shedding light on a potential link between GLP-1 receptor agonists and long-term vision outcomes, with findings suggesting these therapies may be associated with a lower risk of legal blindness in patients with type 2 diabetes
Despite their exploding popularity, the current GLP-1 injections (semaglutide though is also orally available) face accessibility issues due to cost and adverse effects and thus the next big move for the space, an easy to - pop pill could be lucrative, for which clinical trials are already well underway
Key Benefits: No injections required
Our concern is patients who lose weight quickly and without significantly changing their lifestyle are prone to gaining more weight once they stop.
